Whole-exome sequencing in patients with ichthyosis reveals modifiers associated with increased IgE levels and allergic sensitizations - 06/01/15
Doi : 10.1016/j.jaci.2014.09.042
Dimitra Kiritsi, MD a, Manthoula Valari, MD b, Paola Fortugno, PhD c, Ingrid Hausser, PhD d, Lilia Lykopoulou, MD e, Giovanna Zambruno, MD f, Judith Fischer, MD, PhD g, Leena Bruckner-Tuderman, MD a, Thilo Jakob, MD a, Cristina Has, MD a 
a Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany
g Institute for Human Genetics, Medical Center, University of Freiburg, Freiburg, Germany
b Department of Dermatology, University of Athens, Agia Sofia Children's Hospital, Athens, Greece
e First Department of Pediatrics, University of Athens, Agia Sofia Children's Hospital, Athens, Greece
c Dermatology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
d Institute of Pathology, University Clinic Heidelberg, Heidelberg, Germany
f Laboratory of Molecular and Cellular Biology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy
| Supported by the German Research Foundation (DFG grant HA 5663/2-1 to C.H.) and the “Theodor-Nasemann Scholarship” from Galderma Förderkreis and the German Research Foundation (DFG grant 1795/1-1 to D.K.). |
|
| Disclosure of potential conflict of interest: This work was funded by the German Research Foundation DFG grant HA 5663/2-1 to C. Has and the “Theodor-Nasemann Scholarship” from Galderma Förderkreis and the German Research Foundation DFG grant 1795/1-1 to D. Kiritsi. G. Zambruno's institution has received funding from the Italian Ministry of Health, as has that of P. Fortugno (grant no. RC2014). T. Jakob has received funding from Phadia/Thermo Fisher and has received or has grants pending from Allergopharma, Thermo Fisher Scientific, Birken AG, and Cosmetic Europe, as well as consultancy fees from Phadia/Thermo Fisher, Allergopharma, Novartis, and Jansen Cilag and has received payment for delivering lectures from Stallergenes, ALK-Abelló, Allergies Therapeutics, and Novartis. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 135 - N° 1
P. 280 - janvier 2015 Retour au numéro
Article précédent
- Metagenomic heterogeneity explains dual immune effects of endotoxins
- Susanne Brix, Carsten Eriksen, Jeppe Madura Larsen, Hans Bisgaard
- Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency
- Lien Van Eyck, Michael S. Hershfield, Diana Pombal, Susan J. Kelly, Nancy J. Ganson, Leen Moens, Glynis Frans, Heidi Schaballie, Gert De Hertogh, James Dooley, Xavier Bossuyt, Carine Wouters, Adrian Liston, Isabelle Meyts
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?